Top compounds associated with response to PCDHB14


Feature Type Standardized
Nominal ANOVA
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.016 0.7
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.021 0.7
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.7
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA parbendazole CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.019 0.7
mRNA tigecycline CTRPv2 pan-cancer AAC -0.023 0.7
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.026 0.7
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.017 0.7
Download CSV